Back
Synchrony Financial Vs. Akero Therapeutics Industry Stock Comparison
Buy
81
SYF
Synchrony Financial
Last Price:
$69.32
Seasonality Move:
0.86%
Sell
44
AKRO
Akero Therapeutics
Last Price:
$51.26
Seasonality Move:
45.38%
Buy
81
Synchrony Financial (SYF)
is a Buy
Is Synchrony Financial a Buy, Sell or Hold?
-
The current Synchrony Financial [SYF] share price is $70.88. The Score for SYF is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
-
SYF is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
44
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $52.73. The Score for AKRO is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SYF Stock Price Chart
What is Synchrony Financial's stock price today?
-
The Synchrony Financial share price today is $70.88Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SYF is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $52.73The current trend is moderately bearish and AKRO is experiencing slight buying pressure.
SYF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 17.43 | Buy |
Relative Strength Index (14 RSI): | 74.91 | Buy |
Chaikin Money Flow: | 1378188 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (61.18 - 69.26) | Buy |
Bollinger Bands (100): | (50.8 - 64.02) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.37 | Buy |
Relative Strength Index (14 RSI): | 53.6 | Buy |
Chaikin Money Flow: | 120856 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.86 - 55.26) | Sell |
Bollinger Bands (100): | (40.15 - 52.05) | Buy |
SYF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 70.18 | Buy |
20-day SMA: | 66.32 | Buy |
50-day SMA: | 61.41 | Buy |
200-day SMA: | 59.75 | Buy |
8-day EMA: | 50.49 | Buy |
20-day EMA: | 27.75 | Buy |
50-day EMA: | 12.77 | Buy |
200-day EMA: | 3.43 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 51.62 | Buy |
20-day SMA: | 53.45 | Sell |
50-day SMA: | 49.34 | Buy |
200-day SMA: | 39.34 | Buy |
8-day EMA: | 52.09 | Buy |
20-day EMA: | 52.29 | Buy |
50-day EMA: | 49.9 | Buy |
200-day EMA: | 41.1 | Buy |
Synchrony Financial Earnings Growth & SYF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.09 per share, an increase this year of $1.19 per share, and an increase next year of $0.89 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
Synchrony Financial Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |